NULLBODY
Kyowa Hakko Kirin Co., Ltd.
Application Filed: 2010-01-21
Trademark Application Details
CANCELLED - SECTION 8
| Research |
OneLook
Acronym Finder
|
| Serial Number | 77917378 |
| Registration Number | 3983268 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | 2 |
| Domestic Representative | Darren J. Jones |
| Attorney Name | Darren J. Jones |
| Attorney Docket Number | KYOW-2-1001 |
| Law Office Assigned | L40 |
| Employee Name | PARK, JENNY K |
Timeline
| 2010-01-21 | Application Filed |
| 2011-02-15 | Published for Opposition |
| 2011-06-28 | Location: PUBLICATION AND ISSUE SECTION |
| 2011-06-28 | Trademark Registered |
| 2018-02-02 | Cancelled |
| 2018-02-02 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Kyowa Hakko Kirin Co., Ltd. |
| Address | Ohtemachi 1-chome, Chiyoda-ku 6-1 Tokyo JP |
| Legal Entity Type | Corporation |
| Legal Entity State | JP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 40 |
| U.S. Codes: | 100,103,106 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Host cells for medical or clinical use; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives, urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment of cancer, multi enzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, anti parkinsonism drugs, minor tranquilizers, and anti anxiety agents, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system, anti-bacterial preparations, monolithic preparations, medicinal preparations for the treatment of peptic ulcers, anti -inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations, preparations for improving the metabolism and the peripheral circulation, plasma substitutes and extracorporeal circulation flow improvement preparations, diuretic and anti-hypertensive preparations, in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro x-ray contrast agents for medical use, in vitro diagnostic media, pharmaceutical preparations for the treatment of insomnia and other sleep related diseases |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2010-01-25 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2010-01-26 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF PSEUDO MARK MAILED | 2010-01-27 | 3 MPMK O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2010-04-19 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2010-04-26 | 5 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2010-04-26 | 6 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2010-04-26 | 7 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2010-10-22 | 8 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2010-11-10 | 9 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2010-11-10 | 10 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2010-11-10 | 11 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2010-12-01 | 12 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2010-12-01 | 13 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2010-12-01 | 14 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2010-12-01 | 15 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2010-12-06 | 16 CNSA P: |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2010-12-08 | 17 PREV O:Outgoing Correspondence |
| WITHDRAWN FROM PUB - OG REVIEW QUERY | 2010-12-20 | 18 PBCR Z:Deletion |
| PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2011-01-06 | 19 ZZZX Z:Deletion |
| EXAMINERS AMENDMENT -WRITTEN | 2011-01-06 | 20 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2011-01-06 | 21 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2011-01-06 | 22 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2011-01-06 | 23 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2011-01-06 | 24 CNSA P: |
| ASSIGNED TO LIE | 2011-01-07 | 25 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2011-01-07 | 26 PREV O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2011-02-15 | 27 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2011-02-15 | 28 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2011-04-12 | 29 NOAM E:E-Mail |
| TEAS DELETE 1(B) BASIS RECEIVED | 2011-05-20 | 30 D1BR I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2011-05-24 | 31 AITU A:Allowance for Publication |
| NOTICE OF ALLOWANCE CANCELLED | 2011-05-20 | 32 IUCN S: |
| 1(B) BASIS DELETED; PROCEED TO REGISTRATION | 2011-05-24 | 33 DP1B I:Incoming Correspondence |
| REGISTERED-PRINCIPAL REGISTER | 2011-06-28 | 34 R.PR A:Allowance for Publication |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2011-08-11 | 35 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2011-08-11 | 36 ARAA I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2016-06-28 | 37 REM1 E:E-Mail |
| CANCELLED SEC. 8 (6-YR) | 2018-02-02 | 38 C8.. O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 